Fig. 1

Mutational landscape of Japanese patients with small bowel adenocarcinoma. The somatic mutational profiles of all cases. The upper panel shows the numbers of total mutations in each tumor. The central plot shows the key clinical parameters, below which the recurrent mutated genes for each case are exhibited. The number of the recurrent mutated genes observed per tumor was 0 in 1, 1 in 3, 2 in 12 and > 2 in 6 patients. The median number of significant mutations for each patient was two (range; 0–6). The figure included 25 genes identified in SBA patients (n = 22). The most common genomic alterations found were TP53 (n = 16, 72.7%)